Document is current

Article History

Accepted: 30 July 2025

First Online: 8 September 2025

Declarations

:

: A cross-sectional post-evaluation design was approved by the Bellberry private Human Research Ethics Committee. Deakin University authors were approved to assist analysis and reporting through an ethics exemption 2022-086.

: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. No one has been paid to write this article by a pharmaceutical company or other agency who will benefit financially from its submission. Our Watch commissioned this article to share learnings and further the practices of a sector aiming to prevent violence against women.